Haemonetics Ratios (2009-2025) | HAE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Apr2021	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)	36.35%	47.30%	51.08%	53.34%	51.44%	54.41%	53.07%	51.98%	51.33%	53.73%	53.59%	52.90%	51.24%	52.03%	54.25%	55.53%	58.39%	59.82%	59.50%	59.71%
EBT Margin (Quarter)	-12.17%	-1.32%	8.30%	12.08%	5.78%	9.75%	13.80%	13.83%	10.72%	16.57%	10.32%	13.09%	6.82%	13.90%	12.94%	14.32%	21.40%	14.05%	15.67%	17.69%
EBIT Margin (Quarter)	-9.41%	0.61%	10.22%	13.72%	7.24%	11.77%	15.71%	14.18%	11.58%	17.24%	11.10%	13.67%	8.72%	11.83%	14.96%	16.94%	21.58%	16.76%	17.87%	19.88%
EBITDA Margin (Quarter)	-9.41%	-1.75%	6.01%	9.02%	7.24%	5.02%	8.63%	12.25%	11.58%	13.46%	6.83%	11.77%	8.72%	9.32%	12.14%	4.75%	21.58%	16.76%	17.87%	19.88%
Operating Margin (Quarter)	-9.41%	0.61%	10.22%	13.72%	7.24%	11.77%	15.71%	14.18%	11.58%	17.24%	11.10%	13.67%	8.72%	11.83%	14.96%	16.94%	21.58%	16.76%	17.87%	19.88%
Net Margin (Quarter)	-4.91%	-1.95%	6.19%	8.93%	3.69%	7.61%	11.16%	10.79%	9.65%	13.18%	7.84%	9.29%	5.93%	11.41%	9.79%	10.76%	17.54%	10.59%	11.82%	13.21%
FCF Margin (Quarter)	-4.48%	-6.83%	9.44%	13.77%	12.43%	-1.33%	17.17%	15.58%	-4.42%	3.66%	28.29%	-4.52%	16.72%	-9.84%	11.40%	10.10%	30.52%	4.24%	32.48%	25.73%
Efficiency
Inventory Average (Quarter)	311.16M	324.56M	324.58M	314.20M	299.38M	285.46M	266.28M	255.22M	257.57M	274.29M	287.52M	294.93M	310.61M	345.49M	377.95M	177.85M	169.37M	362.83M	348.37M	328.70M
Assets Average (Quarter)	1,569.00M	1,807.06M	1,797.84M	1,816.44M	1,845.56M	1,840.13M	1,842.82M	1,871.59M	1,906.45M	1,948.54M	1,986.77M	2,105.85M	2,198.01M	2,368.28M	2,533.10M	2,528.25M	2,491.11M	2,456.52M	2,452.12M	2,466.52M
Equity Average (Quarter)	725.41M	704.38M	687.81M	714.66M	740.10M	759.92M	749.72M	752.49M	796.99M	841.31M	879.14M	918.49M	951.64M	932.66M	892.11M	892.86M	863.85M	851.57M	865.74M	880.31M
Invested Capital (Quarter)	1,138.13M	677.08M	991.65M	730.77M	1,238.89M	1,050.42M	1,219.81M	1,052.48M	818.02M	1,357.42M	893.66M	943.32M	1,221.93M	1,588.37M	1,562.65M	1,204.96M	2,045.62M	2,107.08M	2,073.90M	2,136.18M
Asset Utilization Ratio (Quarter)	0.55	0.50	0.52	0.52	0.54	0.56	0.59	0.60	0.61	0.63	0.62	0.60	0.60	0.56	0.54	0.54	0.55	0.55	0.54	0.53
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)	0.97	1.16	1.12	1.06	1.03	1.00	1.12	0.99	0.94	0.88	0.85	0.92	0.84	1.35	1.39	1.35	1.49	1.39	1.44	1.34
Debt Ratio (Quarter)	0.39	0.44	0.43	0.42	0.42	0.42	0.44	0.41	0.40	0.39	0.38	0.40	0.37	0.48	0.49	0.48	0.50	0.50	0.50	0.49
Equity Ratio (Quarter)	0.40	0.38	0.39	0.40	0.40	0.42	0.39	0.41	0.42	0.44	0.44	0.43	0.44	0.36	0.35	0.36	0.33	0.36	0.35	0.37
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-192.31M	-173.46M	-192.42M	-236.88M	-259.50M	-214.95M	-241.20M	-224.00M	-284.47M	-285.72M	-351.00M	-193.98M	-178.80M	-344.43M	-299.28M	-320.85M	-306.76M	-292.90M	-296.43M	-363.37M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	6.82%	5.03%	2.99%	2.76%	5.75%	6.64%	8.37%	8.51%	9.43%	10.45%	9.72%	9.23%	8.69%	7.16%	7.41%	7.93%	11.60%	12.26%	12.75%	13.03%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Haemonetics Ratios (2009-2025) | HAE

Create an account

Sign In

Reset Password